Increased Diabetes Prevalence Due to Medical Advances
|
By HospiMedica International staff writers Posted on 17 May 2016 |
A new study has concluded that the global increase in type 1 diabetes (T1D) mellitus is directly linked to reduced natural selection resulting from improved medical care.
Researchers at the University of Adelaide (UA; Australia) and the University of Zurich (UZH; Switzerland) examined the prevalence of T1D in 118 countries and concurrent changes in life expectancy from 1950 to 2010 to test correlation of T1D to reduced natural selection, as measured by the Biological State Index. To do so, they first obtain country-specific estimates of T1D prevalence, life expectancy, obesity prevalence rate, urbanization rates, per capita sugars consumption, and per capita gross domestic product (GDP).
The data obtained were then matched to T1D prevalence in all the countries, which were also grouped to study associations in different geographical regions. After applying the Biological State Index to the data, they found that the rapid worldwide increase in T1D over the last few decades was directly linked with increases in human life expectancy, especially in Western countries, and therefore a reduction in natural selection. The study was published on March 2, 2106, in BMJ Open Diabetes Research & Care.
“The current prevailing paradigm on the increasing prevalence of T1D is that environmental pressures are now able to trigger genotypes. Currently, medical gene intervention in modern medicine at this stage cannot remove T1D genes, and eugenics can offer no direction due to ethics issue,” concluded study co-author Wen-Peng You, PhD, of UA. “Study of T1D epidemiology based on prevalence/incidence T1D data of all age groups has become imperative, as it may offer optimal solution to address, or at least slow down, T1D genetic load increases in different populations.”
“Natural selection is one of the major evolutionary forces that inform changes in our genes, across populations and over generations. This is the first major disease we have shown that is accumulating due to a relaxation of natural selection over time,” said study co-author Professor Maciej Henneberg, PhD, of UA and UZH. “It's unlikely this situation will ever be reversed, meaning that in order to overcome the problems associated with type 1 diabetes for our population, some form of gene therapy to repair the faulty genes may need to be considered.”
Natural selection, one of the basic mechanisms of evolution, is the differential survival and fertility of individuals due to differences in phenotype that reflect genetic differences. In modern society, natural selection still acts on all members of a population, selecting those that have an increased reproductive success due to survival and/or fertility. The Biological State Index takes into account potential loss of reproductive success by dying at an earlier age. The effect of natural selection on contemporary populations is declining due to modern medicine.
Related Links:
University of Adelaide
University of Zurich
Researchers at the University of Adelaide (UA; Australia) and the University of Zurich (UZH; Switzerland) examined the prevalence of T1D in 118 countries and concurrent changes in life expectancy from 1950 to 2010 to test correlation of T1D to reduced natural selection, as measured by the Biological State Index. To do so, they first obtain country-specific estimates of T1D prevalence, life expectancy, obesity prevalence rate, urbanization rates, per capita sugars consumption, and per capita gross domestic product (GDP).
The data obtained were then matched to T1D prevalence in all the countries, which were also grouped to study associations in different geographical regions. After applying the Biological State Index to the data, they found that the rapid worldwide increase in T1D over the last few decades was directly linked with increases in human life expectancy, especially in Western countries, and therefore a reduction in natural selection. The study was published on March 2, 2106, in BMJ Open Diabetes Research & Care.
“The current prevailing paradigm on the increasing prevalence of T1D is that environmental pressures are now able to trigger genotypes. Currently, medical gene intervention in modern medicine at this stage cannot remove T1D genes, and eugenics can offer no direction due to ethics issue,” concluded study co-author Wen-Peng You, PhD, of UA. “Study of T1D epidemiology based on prevalence/incidence T1D data of all age groups has become imperative, as it may offer optimal solution to address, or at least slow down, T1D genetic load increases in different populations.”
“Natural selection is one of the major evolutionary forces that inform changes in our genes, across populations and over generations. This is the first major disease we have shown that is accumulating due to a relaxation of natural selection over time,” said study co-author Professor Maciej Henneberg, PhD, of UA and UZH. “It's unlikely this situation will ever be reversed, meaning that in order to overcome the problems associated with type 1 diabetes for our population, some form of gene therapy to repair the faulty genes may need to be considered.”
Natural selection, one of the basic mechanisms of evolution, is the differential survival and fertility of individuals due to differences in phenotype that reflect genetic differences. In modern society, natural selection still acts on all members of a population, selecting those that have an increased reproductive success due to survival and/or fertility. The Biological State Index takes into account potential loss of reproductive success by dying at an earlier age. The effect of natural selection on contemporary populations is declining due to modern medicine.
Related Links:
University of Adelaide
University of Zurich
Latest Critical Care News
- AI-Enhanced ECG Screens for Heart Failure Risk in Resource-Limited Settings
- Battery-Free ECG Patch Enables Continuous Arrhythmia Monitoring
- Spinal Cord Interface Restores Bladder Control in Preclinical Study
- Rapid Clotting Gel Improves Emergency Bleeding Control
- AI Tool Predicts In-Hospital Cardiac Arrest Minutes in Advance
- Magnetic Control System Enables Precise Navigation of Miniature Medical Devices
- Shelf-Stable Synthetic Platelets Could Enable Prehospital Hemorrhage Control
- Noninvasive AI Test Aims to Enable Earlier Pulmonary Hypertension Detection
- Blood-Filtering Device May Prolong Pregnancy in Severe Early Preeclampsia
- Noninvasive Skull Sensor Detects Early Deterioration in Acute Brain Injury
- Automated Robotic Imaging System Enhances Full-Body Skin Cancer Screening
- Bacteria-Resistant Urinary Catheter Coating Reduces Infections and Antibiotic Use
- New Brain-Computer Interface Targets Treatment-Resistant Depression
- Sensor-Integrated Airway Stent Enables Continuous Remote Monitoring
- Graphene-Based Material Selectively Eliminates Bacteria While Sparing Human Cells
- Flexible Plastic Film Uses Nanostructures to Destroy Viruses
Channels
Artificial Intelligence
view channelFacial Image Analysis Tracks Biological Aging, Predicts Cancer Outcomes
Biological aging is the progressive loss of physiological function that may diverge from chronological age. In cancer care, clinicians need simple tools that reflect dynamic changes in patient resilience... Read more
AI Model Uses Eye Imaging to Identify Risk of Major Systemic Diseases
Early detection of systemic disease risk remains a persistent challenge in population health screening. Cardiometabolic conditions such as diabetes, heart disease, and stroke often progress without symptoms... Read moreSurgical Techniques
view channel
Smart Soft Sensors Provide Real-Time Force Feedback in Minimally Invasive Surgery
Minimally invasive surgery reduces recovery time and postoperative pain but limits tactile feedback for surgeons. Loss of force perception can increase the risk of tissue injury and complicate delicate... Read more
Ultrasonic Fine-Needle Biopsy Tool Improves Salivary Gland Tumor Diagnosis
Accurate tissue sampling is central to cancer work-ups, yet fine-needle aspiration often yields too little material for a reliable diagnosis in head and neck lesions. Core needle biopsy can recover tissue... Read more
Patient-Specific 3D-Printed Guide Improves Precision in Breast-Conserving Surgery
Achieving clear margins during breast-conserving surgery remains challenging, especially when poorly defined tumor edges lead to repeat operations. Positive margins occur in about 20% of cases and in 30–40%... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read more
AI System Detects and Quantifies Chronic Subdural Hematoma
Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more
Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read morePoint of Care
view channel
Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
HemoSonics (Durham, NC, USA) announced on May 5, 2026 that the company's Quantra Hemostasis System for Obstetric Procedures won Silver in the 2026 Edison Awards in the Women’s Health and Reproductive Innovations... Read moreBusiness
view channel
Olympus Partnership Aims to Expand Access to Robot-Assisted Endoscopic Therapy
Olympus has signed an exclusive global distribution agreement with EndoRobotics Co., Ltd., under which robot-assisted technologies developed by EndoRobotics will be distributed worldwide as part of the... Read more







